| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/06/1994 | WO1994000482A1 Isolation and characterization of the growth hormone releasing hormone receptor |
| 01/06/1994 | WO1994000481A1 Pharmaceutical composition containing botulinum b complex |
| 01/06/1994 | WO1994000469A1 Novel tyrosine kinase |
| 01/06/1994 | WO1994000461A1 Inhibitors of retroviral proteases |
| 01/06/1994 | WO1994000440A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/06/1994 | WO1994000421A1 Bicyclooctane and bicycloheptane derivatives |
| 01/06/1994 | WO1994000156A1 Polymer-bound paclitaxel derivatives |
| 01/06/1994 | WO1994000153A1 Vaccine composition containing adjuvants |
| 01/06/1994 | WO1994000148A1 Synthetic peptides for the treatment of myasthenia gravis |
| 01/06/1994 | WO1994000147A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |
| 01/06/1994 | WO1994000146A1 Treatment for sensitive teeth |
| 01/06/1994 | WO1994000145A1 Targeted delivery of growth factors for bone regeneration |
| 01/06/1994 | WO1994000144A1 Anti-aggregatory agents for platelets |
| 01/06/1994 | WO1994000143A1 Blocking intercellular interactions with cd43 chimeric molecules |
| 01/06/1994 | WO1994000142A1 Emulsified preparation of aureobasidin |
| 01/06/1994 | WO1994000141A1 Glutathione as chemoprotective agent |
| 01/06/1994 | WO1994000140A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | WO1994000137A1 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections |
| 01/06/1994 | WO1994000136A1 A COMBINATION OF ANTI-erbB-2 MONOCLONAL ANTIBODIES AND METHOD OF USING |
| 01/06/1994 | WO1994000133A1 Use of mullerian inhibiting substance for treating tumors and for modulating class 1 major histocompatibility antigen expression |
| 01/06/1994 | WO1994000131A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | WO1994000128A1 ORAL 1α-HYDROXYPREVITAMIN D |
| 01/06/1994 | WO1994000109A1 Dermatological agent for aiding oxygen transport in the skin |
| 01/06/1994 | WO1994000098A1 Cosmetic containing phospholipids and fluorocarbon compounds |
| 01/06/1994 | WO1994000097A1 Topical application composition |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1994000016A1 Biochemical deactivation of rna viruses |
| 01/06/1994 | WO1993023434A3 Bpi-immunoglobulin fusion proteins |
| 01/06/1994 | EP0583359A4 Method for treating hypothermia. |
| 01/06/1994 | CA2139350A1 Oxazolone derived materials |
| 01/06/1994 | CA2139323A1 Targeted delivery of growth factors for bone regeneration |
| 01/06/1994 | CA2139136A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | CA2139127A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 01/06/1994 | CA2139105A1 Angiotensin iv peptides and receptor |
| 01/06/1994 | CA2138992A1 Glutathione as chemoprotective agent |
| 01/06/1994 | CA2138988A1 Recombinant baculoviruses containing insect cellular promoter |
| 01/06/1994 | CA2138948A1 Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum |
| 01/06/1994 | CA2138807A1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/06/1994 | CA2138374A1 Neuropeptide y antagonists |
| 01/06/1994 | CA2138281A1 Prophylactic and remedy for viral diseases in respiratory tract |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | CA2137779A1 Purification of kringle containing proteins, and especially t-pa |
| 01/06/1994 | CA2137674A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |
| 01/06/1994 | CA2120745A1 A combination of anti-erbb-2 monoclonal antibodies and method of using |
| 01/06/1994 | CA2116661A1 Biochemical deactivation of rna viruses |
| 01/06/1994 | CA2116246A1 Human monoclonal anti-rhesus (d) antibodies and cell lines producing same |
| 01/06/1994 | CA2116109A1 Multimeric forms of human rhinovirus receptor protein |
| 01/06/1994 | CA2112482A1 Polymer-bound paclitaxel derivatives |
| 01/05/1994 | EP0577544A1 Novel cyclosporins having modifications at position 1 |
| 01/05/1994 | EP0577481A1 New therapeutic application of a Thyme extract and in-vitro methods for inhibiting the growth and urease activity of Helicobacter pylori |
| 01/05/1994 | EP0577394A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/05/1994 | EP0577243A2 Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection |
| 01/05/1994 | EP0577225A1 Diagnosis and treatment of inflammation |
| 01/05/1994 | EP0577171A2 Use of piperazine acetamide derivatives against reperfusion damage |
| 01/05/1994 | EP0577151A1 Use of GHL-Cu as antiinflammatory agent |
| 01/05/1994 | EP0577144A1 Detection of a unique Chlamydia strain associated with acute respiratory disease |
| 01/05/1994 | EP0576988A1 Isolation and characterization of the growth hormone releasing hormone receptor |
| 01/05/1994 | EP0576953A2 Production of human cathepsin and its use |
| 01/05/1994 | EP0576938A1 Composition of digestive enzymes and salts of bile acids and process for preparation thereof |
| 01/05/1994 | EP0576898A2 Linear peptides |
| 01/05/1994 | EP0576792A2 Plasmids and process for producing recombinant desulphatohirudin HV-1 peptide |
| 01/05/1994 | EP0576669A1 Novel methods and compositions for treatment of angiogenic diseases |
| 01/05/1994 | EP0576623A1 Binding domains in notch and delta proteins |
| 01/05/1994 | EP0576609A1 Receptors for bombesin-like peptides |
| 01/05/1994 | EP0576589A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 01/05/1994 | EP0576570A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 01/05/1994 | EP0576522A1 A single dose vaccination system |
| 01/05/1994 | EP0576483A1 Biocidal proteins |
| 01/05/1994 | EP0576452A1 Products containing verapamil and trandolapril. |
| 01/05/1994 | EP0576439A1 Monoclonal antibody against lps core |
| 01/05/1994 | EP0487615B1 Ferritin analogs |
| 01/05/1994 | EP0396733B1 Improved extraction methods for preparing thromboplastin reagents |
| 01/05/1994 | DE4221836A1 New mistletoe lectin - with immunomodulatory activity, useful for cancer adjuvant therapy |
| 01/05/1994 | DE4221268A1 Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut Using a dermatological to support the oxygen transport into skin |
| 01/05/1994 | DE4221255A1 Phospholipide enthaltendes Kosmetikum Phospholipids containing cosmetic |
| 01/05/1994 | CN1080188A Prevention of retinal injury and degeneration by specific factors |
| 01/05/1994 | CN1080172A Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 01/05/1994 | CN1023409C Production method of nutritive liquid |
| 01/04/1994 | US5276494 High-speed printing device having a particle trap arranged in the paper channel |
| 01/04/1994 | US5276137 Enkephalin derivatives |
| 01/04/1994 | US5276136 Laminin A chain polypeptides from the amino terminal globular domain |
| 01/04/1994 | US5276031 Method for treating renal disease |
| 01/04/1994 | US5276017 In vitro fertilization and implantation |
| 01/04/1994 | US5276016 Alleviates aids symptoms |
| 01/04/1994 | US5276015 Lipoprotein associated coagulation inhibitor or tissue factor pathway inhibitor |
| 01/04/1994 | US5276014 Human growth factor |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275950 Process for the preparation of a renin inhibiting compound |
| 01/04/1994 | US5275946 Thrombolytic agents with modified kringle domains |
| 01/04/1994 | US5275819 Drug loaded pollen grains with an outer coating for pulsed delivery |
| 01/04/1994 | US5275815 Bacillus thuringiensio NRRL B-18721 active against dipteran pests |
| 01/04/1994 | US5275812 Method of treatment for myocardial infarction |
| 12/31/1993 | CA2099698A1 Peptide derivatives involved in cellular adhesion processes, process for their preparation and pharmaceutical compositions comprising thereof |
| 12/31/1993 | CA2076944A1 Ajoene as an agent for inhibiting symptoms and growth of aids virus and changes at the cellular level |
| 12/30/1993 | CA2099233A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 12/29/1993 | EP0576294A2 Chondroitinase, process for preparing the same, and pharmaceutical composition comprising the same |
| 12/29/1993 | EP0576279A1 Hydrophilic cream for the delivery of therapeutic agents |
| 12/29/1993 | EP0576192A2 Polyoxymethylene-oxyethylene copolymers in conjunction with biomolecules |
| 12/29/1993 | EP0576093A1 Human monoclonal anti-Rhesus (D) antibodies and cell lines producing same |
| 12/29/1993 | EP0576049A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |